which is an inhibitor of tyrosine kinases (TK) involved in hematopoiesis [217] including not only CSF1R but also c-KIT (stem cell factor receptor), Flt-3 (Fms-related tyrosine kinase 3), and VEGFR, has been studied in patients with advanced solid tumors. The administration of pexidartinib...